➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Express Scripts
Mallinckrodt
AstraZeneca
Boehringer Ingelheim

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

PREVALITE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Prevalite patents expire, and what generic alternatives are available?

Prevalite is a drug marketed by Upsher Smith Labs and is included in one NDA.

The generic ingredient in PREVALITE is cholestyramine. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.

US ANDA Litigation and Generic Entry Outlook for Prevalite

A generic version of PREVALITE was approved as cholestyramine by SANDOZ on August 15th, 1996.

  Start Trial

US Patents and Regulatory Information for PREVALITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith Labs PREVALITE cholestyramine POWDER;ORAL 073263-001 Feb 22, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs PREVALITE cholestyramine POWDER;ORAL 073263-002 Oct 30, 1997 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Moodys
Colorcon
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.